Development of a fusion partner cell line for efficient production of human monoclonal antibodies from peripheral blood lymphocytes

Human Antibodies

Volumn 11, Issue 3, 2002, Pages 85-96

  Kalantarov, Gary F ^a   Rudchenko, Sergey A ^a   Lobel, Leslie ^a,b   Trakht, Ilya ^a  

^a Columbia University ^*  (United States)

^b BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

Cancer; Heteromyeloma; Human monoclonal antibodies; Trioma

Indexed keywords

MONOCLONAL ANTIBODY; TUMOR ANTIGEN;

ARTICLE; BREAST CARCINOMA; CANCER CELL CULTURE; CANCER TISSUE; CELL LINE; CONTROLLED STUDY; HUMAN; HUMAN CELL; HYBRIDOMA CELL CULTURE; LYMPH NODE; LYMPHOCYTE; MYELOMA CELL; PRIORITY JOURNAL; SPLEEN; ANIMAL; BIOSYNTHESIS; BREAST TUMOR; CELL FUSION; IMMUNOLOGY; KARYOTYPING; MOUSE;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, NEOPLASM; BREAST NEOPLASMS; CELL FUSION; CELL LINE; HUMANS; KARYOTYPING; LYMPHOCYTES; MICE;

EID: 0036444473     PISSN: 10932607     EISSN: None     Source Type: Journal    
DOI: 10.3233/hab-2002-11305     Document Type: Article

References (39)

1. P.G. Abrams, J.A. Knost, G. Clarke, S. Wilburn, R.K. Oldham and K.A. Foon, Determination of the optimal human cell lines for development of human hybridomas, J Immunol 131 (1983), 1201-1204.
2. T. Hundhausen, R. Laus and W. Muller-Ruchholtz, New parental cell lines for generating human hybridomas, J Immunol Methods 153 (1992), 21-29.
3. S.S. Alkan, F. Mestel, J. Jiricka and K. Blaser, Estimation of heterokaryon formation and hybridoma growth in murine and human cell fusions, Hybridoma 6 (1987), 371-379.
4. T. Brodin, L. Olsson and H.O. Sjogren, Cloning of human hybridoma, myeloma and lymphoma cell lines using enriched human monocytes as feeder layer, J Immunol Methods 60 (1983), 1-7.
5. S.P. Cole, B.G. Campling, T. Atlaw, D. Kozbor and J.C. Roder, Human monoclonal antibodies, Mol Cell Biochem 62 (1984), 109-120.
6. K. Koda, M.C. Glassy and H.R. Chang, Generation of human monoclonal antibodies against colon cancer, Arch Surg 125 (1990), 1591-1597.
7. D. Kozbor, D. Dexter and J.C. Roder, A comparative analysis of the phenotypic characteristics of available fusion partners for the construction of human hybridomas, Hybridoma 2 (1983), 7-16.
8. P. Casali, G. Inghirami, M. Nakamura, T.F. Davies and A.L. Notkins, Human monoclonals from antigen-specific selection of B lymphocytes and transformation by EBV, Science 234 (1986), 476-479.
9. D. Kozbor and J.C. Roder, Requirements for the establishment of high-titered human monoclonal antibodies against tetanus toxoid using the Epstein-Barr virus technique, J Immunol 127 (1981), 1275-1280.
10. J.C. Roder, S.P. Cole and D. Kozbor, The EBV-hybridoma technique, Methods Enzymol 121 (1986), 140-167.
11. L. Ostberg and E. Pursch, Human X (mouse X human) hybridomas stably producing human antibodies, Hybridoma 2 (1983), 361-367.
12. F.J. Hsu, L. Kwak, M. Campbell, T. Liles, D. Czerwinski, S. Hart, A. Syrengelas, R. Miller and R. Levy, Clinical trials of idiotype-specific vaccine in B-cell lymphomas, Ann N Y Acad Sci 690 (1993), 385-387.
13. W.L. Carroll, K. Thielemans, J. Dilley and R. Levy, Mouse x human heterohybridomas as fusion partners with human B cell tumors, J Immunol Methods 89 (1986), 61-72.
14. D.G. Maloney, S. Brown, D.K. Czerwinski, T.M. Liles, S.M. Hart, R.A. Miller and R. Levy, Monoclonal anti-idiotype antibody therapy of B-cell lymphoma: The addition of a short course of chemotherapy does not interfere with the antitumor effect nor prevent the emergence of idiotype-negative variant cells, Blood 80 (1992), 1502-1510.
15. M. Bendandi, C.D. Gocke, C.B. Kobrin, F.A. Benko, L.A. Sternas, R. Pennington, T.M. Watson, C.W. Reynolds, B.L. Gause, P.L. Duffey, E.S. Jaffe, S.P. Creekmore, D.L. Longo and L.W. Kwak, Complete molecular remissions induced by patient-specific vaccination plus granulocyte-monocyte colony-stimulating factor against lymphoma, Nat Med 5 (1999), 1171-1177.
16. P.A. Ruffini, A. Biragyn and L.W. Kwak, Recent advances in multiple myeloma immunotherapy, Biomed Pharmacother 56 (2002), 129-132.
17. M.C. Glassy, H.H. Handley, H. Hagiwara and I. Royston, UC 729-6, a human lymphoblastoid B-cell line useful for generating antibody-secreting human-human hybridomas, Proc Natl Acad Sci USA 80 (1983), 6327-6331.
18. M. Pratt, A. Mikhalev and M.C. Glassy, The generation of Ig-secreting UC 729-6 derived human hybridomas by electrofusion, Hybridoma 6 (1987), 469-477.
19. A. Karpas, A. Dremucheva and B.H. Czepulkowski, A human myeloma cell line suitable for the generation of human monoclonal antibodies, Proc Natl Acad Sci USA 98 (2001), 1799-1804.
20. M. Vaisbourd, O. Ignatovich, A. Dremucheva, A. Karpas and G. Winter, Molecular characterization of human monoclonal antibodies derived from fusions of tonsil lymphocytes with a human myeloma cell line, Hybrid Hybridomics 20 (2001), 287-292.
21. J.F. Kearney, A. Radbruch, B. Liesegang and K. Rajewsky, A new mouse myeloma cell line that has lost immunoglobulin expression but permits the construction of antibody-secreting hybrid cell lines, J Immunol 123 (1979), 1548-1550.
22. G. Kohler and C. Milstein, Continuous cultures of fused cells secreting antibody of predefined specificity, Nature 256 (1975), 495-497.
23. G. Kohler and C. Milstein, Derivation of specific antibody-producing tissue culture and tumor lines by cell fusion, Eur J Immunol 6 (1976), 511-519.
24. A.S. Antonov, M.A. Nikolaeva, T.S. Klueva, Y. Romanov, V.R. Babaev, V.B. Bystrevskaya, N.A. Perov, V.S. Repin and V.N. Smirnov, Primary culture of endothelial cells from atherosclerotic human aorta. Part 1. Identification, morphological and ultrastructural characteristics of two endothelial cell subpopulations, Atherosclerosis 59 (1986), 1-19.
25. M. Seabright, A rapid banding technique for human chromosomes, Lancet 2 (1971), 971-972.
26. R.B. Effros, E. Zeller, L. Dillard and R.L. Walford, Detection of antibodies to cell surface antigens by a simplified cellular ELISA (CELISA), Tissue Antigens 25 (1985), 204-211.
27. L. Wollweber and H.G. Wisniewski, Antigen spot test for the detection of specific antibodies in the nanogram range by means of the PAP-technique, Acta Histochem Suppl 33 (1986), 305-307.
28. C.A. Borrebaeck, L. Danielsson and S.A. Moller, Human monoclonal antibodies produced from L-leucine methyl ester-treated and in vitro immunized peripheral blood lymphocytes, Biochem Biophys Res Commun 148 (1987), 941-946.
29. D. Gussow and G. Seemann, Humanization of monoclonal antibodies, Methods Enzymol 203 (1991), 99-121.
30. C.A. Kettleborough, J. Saldanha, V.J. Heath, C.J. Morrison and M.M. Bendig, Humanization of a mouse monoclonal antibody by CDR-grafting: The importance of framework residues on loop conformation, Protein Eng 4 (1991), 773-783.
31. G.M. Studnicka, S. Soares, M. Better, R.E. Williams, R. Nadell and A.H. Horwitz, Human-engineered monoclonal antibodies retain full specific binding activity by preserving non-CDR complementarity-modulating residues, Protein Eng 7 (1994), 805-814.
32. H. Wu, Y. Nie, W.D. Huse and J.D. Watkins, Humanization of a murine monoclonal antibody by simultaneous optimization of framework and CDR residues, J Mol Biol 294 (1999), 151-162.
33. M. Baca, L.G. Presta, S.J. O'Connor and J.A. Wells, Antibody humanization using monovalent phage display, J Biol Chem 272 (1997), 10678-10684.
34. C. Rader, D.A. Cheresh and C.F. Barbas III, A phage display approach for rapid antibody humanization: Designed combinatorial V gene libraries, Proc Natl Acad Sci USA 95 (1998), 8910-8915.
35. H.E. Chadd and S.M. Chamow, Therapeutic antibody expression technology, Curr Opin Biotechnol 12 (2001), 188-194.
36. W.A. Wells, Eek, a XenoMouse: Abgenix, Inc, Chem Biol 7 (2000), R185-R186.
37. C.G. Davis, M.L. Gallo and J.R. Corvalan, Transgenic mice as a source of fully human antibodies for the treatment of cancer, Cancer Metastasis Rev 18 (1999), 421-425.
38. A. Jakobovits, Production and selection of antigen-specific fully human monoclonal antibodies from mice engineered with human Ig loci, Adv Drug Deliv Rev 31 (1998), 33-42.
39. R.L. Raison, K.Z. Walker, C.R. Halnan, D. Briscoe and A. Basten, Loss of secretion in mouse-human hybrids need not be due to the loss of a structural gene, J Exp Med 156 (1982), 1380-1389.